| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.009 |